Cork's Solvotrin signs Active Iron distribution deal in US
Gary Powers, of Ortho Molecular Products, with Solvotrin Therapeutics's Pat O’Flynn and Ronan McClafferty announced the three-year deal at the Irish American Partnership Breakfast in Chicago last Friday.
Cork supplements firm Solvotrin has secured a distribution deal with a US company in the hopes it will secure $15m in sales for its Active Iron supplement over three years.
The deal is with Ortho Molecular Products for the distribution of Active Iron in the US healthcare practitioner channel populated by doctors, nutritionists, and accredited healthcare specialists.
The announcement was made at the Irish American Partnership Breakfast in Chicago last Friday as part of Enterprise Ireland’s St Patrick’s Day programme of US business events — which was attended by business executives and the minister for health, Jennifer Carroll MacNeill.
Headquartered in Cork and headed by CEO and founder Pat O’Flynn, Solvotrin Therapeutics has a team of 19 — with research and development located at Trinity College Dublin (TCD).
Priority markets for the Active Iron brand have been Britain, Ireland, North America, and China.
"We are delighted to partner with Ortho Molecular Products and to be here in the US this week to celebrate Irish business," CEO Pat O’Flynn said.
“Solvotrin has very supportive backers, not least our long-term partnership with Enterprise Ireland.
"With Ireland’s close trading relationship in pharma, chemicals, and medical instruments, new supply chain partnerships will be core to growing the company on a global scale."
Active Iron is a range of oral iron products that are patent-protected and backed by clinical studies. The US partnership will introduce the product directly to healthcare providers.
The chief operating officer at Solvotrin Therapeutics, Ronan McClafferty, said the companies’ shared values, deep expertise, and strong relationships with healthcare providers will ensure their product makes a meaningful impact in the US market.
“With its unique formulation and strong clinical backing, our supplement portfolio delivers significant benefit to patients who need iron support, including women with increased nutritional demands”, he told the US business event.
A collection of the latest business articles and business analysis from Cork.
